Endometriosis and Risk of Ovarian and Endometrial Cancers in a Large Prospective Cohort of U.S. Nurses

Overview

Journal Cancer Causes Control

Specialties Oncology
Public Health

Date 2017 Mar 17

PMID 28299512

Citations 31

Authors

Elizabeth M Poole

Wayne T Lin

Marina Kvaskoff

Immaculata De Vivo

Kathryn L Terry

Stacey A Missmer

Affiliations

Soon will be listed here.

Abstract

Purpose: Endometriosis is associated with ovarian cancer, but the relation with endometrial cancer is unclear. Prior studies generally were retrospective and had potential limitations, including use of self-reported endometriosis, failure to account for delays between symptom onset and endometriosis diagnosis, and changes in risk factors post-endometriosis diagnosis. We evaluated whether these limitations obscured a weak association with endometrial cancer and the extent to which these limitations impacted associations with ovarian cancer.

Methods: Cox proportional hazards regression models were used to assess associations between endometriosis and cancer risk, evaluating the impacts of self-reported vs. laparoscopically confirmed endometriosis, delayed diagnosis, and post-endometriosis diagnosis changes in risk factor exposures on relative risk estimates.

Results: Over 18 years of follow-up, we identified 228 ovarian and 166 endometrial cancers among 102,025 and 97,109 eligible women, respectively. Self-reported endometriosis was associated with ovarian cancer [relative risk (RR): 1.81; 95% confidence interval (CI): 1.26-2.58]; this association was stronger for laparoscopically confirmed endometriosis (HR: 2.14; 95% CI 1.45-3.15). No association was observed with endometrial cancer (self-report RR: 0.78; 95% CI 0.42-1.44; laparoscopic-confirmation RR: 0.76; 95% CI 0.35-1.64). Accounting for diagnosis delays or post-endometriosis diagnosis changes in risk factors had a little impact.

Conclusions: This study adds to the evidence that endometriosis is not strongly linked to endometrial cancer risk and that the association with ovarian cancer is robust to misclassification, diagnostic delay, and changes in exposures post-endometriosis diagnosis. Our analysis suggests that confounding and misclassification do not obscure a weak association for endometrial cancer risk, although our results should be replicated.

Citing Articles

Infertility and Risk of Ovarian Cancer in the Women's Health Initiative.

Harris H, Lind K, Fest S, Thomson C, Saquib N, Shadyab A Cancer Causes Control. 2025; .

PMID: 39875703 DOI: 10.1007/s10552-025-01962-z.

Endometriosis and uterine fibroids and risk of premature mortality: prospective cohort study.

Wang Y, Farland L, Gaskins A, Wang S, Terry K, Rexrode K BMJ. 2024; 387:e078797.

PMID: 39567014 PMC: 11577545. DOI: 10.1136/bmj-2023-078797.

Simultaneous Endometrial Cancer with Extensive Pelvic and Vulvar Endometriosis: A Case Report.

Aminimoghaddam S, Abolghasem N, Jamshidnezhad N J Reprod Infertil. 2024; 25(2):163-168.

PMID: 39157796 PMC: 11327419. DOI: 10.18502/jri.v25i2.16011.

Endometriosis-Associated Ovarian Cancer: From Molecular Pathologies to Clinical Relevance.

Steinbuch S, Luss A, Eltrop S, Gotte M, Kiesel L Int J Mol Sci. 2024; 25(8).

PMID: 38673891 PMC: 11050613. DOI: 10.3390/ijms25084306.

Endometrial Cancer with and without Endometriosis: Clinicopathological Differences.

Minamikawa T, Yachida N, Takahashi K, Saito K, Sekizuka T, Akashi H Cancers (Basel). 2023; 15(23).

PMID: 38067342 PMC: 10705732. DOI: 10.3390/cancers15235635.

References

Felix A, Weissfeld J, Stone R, Bowser R, Chivukula M, Edwards R . Factors associated with Type I and Type II endometrial cancer. Cancer Causes Control. 2010; 21(11):1851-6. PMC: 2962676. DOI: 10.1007/s10552-010-9612-8. View

Zucchetto A, Serraino D, Polesel J, Negri E, De Paoli A, Dal Maso L . Hormone-related factors and gynecological conditions in relation to endometrial cancer risk. Eur J Cancer Prev. 2009; 18(4):316-21. DOI: 10.1097/cej.0b013e328329d830. View

Burney R, Giudice L . Pathogenesis and pathophysiology of endometriosis. Fertil Steril. 2012; 98(3):511-9. PMC: 3836682. DOI: 10.1016/j.fertnstert.2012.06.029. View

Melin A, Sparen P, Bergqvist A . The risk of cancer and the role of parity among women with endometriosis. Hum Reprod. 2007; 22(11):3021-6. DOI: 10.1093/humrep/dem209. View

Kobayashi H, Sumimoto K, Moniwa N, Imai M, Takakura K, Kuromaki T . Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan. Int J Gynecol Cancer. 2007; 17(1):37-43. DOI: 10.1111/j.1525-1438.2006.00754.x. View

McConechy M, Anglesio M, Kalloger S, Yang W, Senz J, Chow C . Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas. J Pathol. 2011; 223(5):567-73. DOI: 10.1002/path.2848. View

Melin A, Sparen P, Persson I, Bergqvist A . Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod. 2006; 21(5):1237-42. DOI: 10.1093/humrep/dei462. View

Dinulescu D, Ince T, Quade B, Shafer S, Crowley D, Jacks T . Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med. 2004; 11(1):63-70. DOI: 10.1038/nm1173. View

Lu Y, Cuellar-Partida G, Painter J, Nyholt D, Morris A, Fasching P . Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. Hum Mol Genet. 2015; 24(20):5955-64. PMC: 4581608. DOI: 10.1093/hmg/ddv306. View

10.

Venn A, Watson L, Bruinsma F, Giles G, Healy D . Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet. 1999; 354(9190):1586-90. DOI: 10.1016/S0140-6736(99)05203-4. View

11.

McConechy M, Ding J, Senz J, Yang W, Melnyk N, Tone A . Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles. Mod Pathol. 2013; 27(1):128-34. PMC: 3915240. DOI: 10.1038/modpathol.2013.107. View

12.

Kurman R, Shih I . Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm. Hum Pathol. 2011; 42(7):918-31. PMC: 3148026. DOI: 10.1016/j.humpath.2011.03.003. View

13.

Brinton L, Sakoda L, Sherman M, Frederiksen K, Kjaer S, Graubard B . Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer Epidemiol Biomarkers Prev. 2005; 14(12):2929-35. DOI: 10.1158/1055-9965.EPI-05-0394. View

14.

Svenssen Munksgaard P, Blaakaer J . The association between endometriosis and gynecological cancers and breast cancer: a review of epidemiological data. Gynecol Oncol. 2011; 123(1):157-63. DOI: 10.1016/j.ygyno.2011.06.017. View

15.

Brinton L, Felix A, McMeekin D, Creasman W, Sherman M, Mutch D . Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial. Gynecol Oncol. 2013; 129(2):277-84. PMC: 4006113. DOI: 10.1016/j.ygyno.2013.02.023. View

16.

Nnoaham K, Hummelshoj L, Webster P, DHooghe T, Nardone F, De Cicco Nardone C . Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril. 2011; 96(2):366-373.e8. PMC: 3679489. DOI: 10.1016/j.fertnstert.2011.05.090. View

17.

Giudice L . Clinical practice. Endometriosis. N Engl J Med. 2010; 362(25):2389-98. PMC: 3108065. DOI: 10.1056/NEJMcp1000274. View

18.

de Boer E, Tonkelaar I, Burger C, van Leeuwen F . Validity of self-reported causes of subfertility. Am J Epidemiol. 2005; 161(10):978-86. DOI: 10.1093/aje/kwi120. View

19.

Lee W, Chang W, Wang K, Guo C, Chou Y, Huang N . The Risk of Epithelial Ovarian Cancer of Women With Endometriosis May be Varied Greatly if Diagnostic Criteria Are Different: A Nationwide Population-Based Cohort Study. Medicine (Baltimore). 2015; 94(39):e1633. PMC: 4616839. DOI: 10.1097/MD.0000000000001633. View

20.

Buis C, van Leeuwen F, Mooij T, Burger C . Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis. Hum Reprod. 2013; 28(12):3358-69. DOI: 10.1093/humrep/det340. View